Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.4B | 1.1B | 1.2B | 1.2B |
Cost of revenue | 683M | 583M | 607M | 585M |
Gross profit | 702M | 506M | 579M | 569M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 186M | 211M | 165M | 173M |
Operating income | 452M | 237M | 358M | 341M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 48M | 54M | 50M | 52M |
Other income expense | 23M | 92M | 9M | 57M |
Pretax income | 427M | 275M | 317M | 346M |
Tax provision | 93M | 64M | 78M | 87M |
Net income | 334M | 211M | 239M | 259M |
Basic EPS | 1.2 | 0.7 | 0.8 | 0.9 |
Diluted EPS | 1.2 | 0.7 | 0.8 | 0.9 |
Basic average shares | 283M | 283M | 282M | 282M |
Diluted average shares | 285M | 284M | 284M | 283M |
EBITDA | 516M | 296M | 415M | 398M |
Net income from continuing op. | 334M | 211M | 238M | 260M |
Minority interests | -3M | -1M | -5M | -2M |
Preferred stock dividends | 4M | 3M | 3M | 3M |